BD Max
Device Molecular Diagnostics
PDI 30382904434206
General payments
$30,272
Research payments
$3,037,401
Through program year 2022, $30,272 in general payments and $3,037,401 in research payments were reported against BD Max (Molecular Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $30,272 | 530 |
| 2022 | Research | $2,354,177 | 23 |
| 2021 | Research | $683,224 | 12 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
530 general · 35 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.